Literature DB >> 24927700

Subgroups of Alzheimer's disease: stability of empirical clusters over time.

Jessica Peter1, Ahmed Abdulkadir2, Christoph Kaller3, Dorothee Kümmerer3, Michael Hüll4, Werner Vach5, Stefan Klöppel6.   

Abstract

Although episodic memory impairment is usually the earliest sign of Alzheimer's disease (AD), there are up to 15% of patients presenting with early impairment in non-memory cognitive functions (i.e., atypical AD). Stratifying patients with AD may aid clinical trials. Previous studies divided patients by cognitive profile, focusing on cross-sectional analyses without testing stability of clusters over time. We used principal component analysis followed by cluster analyses in 127 patients with AD based on 24 cognitive scores at 0, 6, 12, and 24 months follow-up. We investigated the definition of clusters and their stability over time as well as interactions of cluster assignment and disease severity. At each time point, six distinct factors and four distinct clusters were extracted that did not differ substantially between time points. Clusters were defined by cognitive profile rather than disease severity. 85% of patients fell into the same cluster twice, 42% three times, and 17% four times. Subjects with focal semantic impairment progressed significantly faster than the other cluster. Longitudinally, focal deficits increased relatively rather than tending toward average disease severity. The observed similar cluster definitions at each time point indicate the validity of the approach. Cluster-specific longitudinal increases of focal impairments and significant between-cluster differences in disease progression make this approach useful for stratified inclusion into clinical trials.

Entities:  

Keywords:  Alzheimer's disease; atypical AD; cluster analysis; clustering; subgroups; subtypes; typical AD

Mesh:

Year:  2014        PMID: 24927700     DOI: 10.3233/JAD-140261

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

1.  Identification of Heterogeneous Cognitive Subgroups in Community-Dwelling Older Adults: A Latent Class Analysis of the Einstein Aging Study.

Authors:  Andrea R Zammit; Charles B Hall; Richard B Lipton; Mindy J Katz; Graciela Muniz-Terrera
Journal:  J Int Neuropsychol Soc       Date:  2018-01-10       Impact factor: 2.892

Review 2.  Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2017-03-22       Impact factor: 21.566

Review 3.  Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials.

Authors:  Ranjan Duara; Warren Barker
Journal:  Neurotherapeutics       Date:  2022-01-27       Impact factor: 6.088

4.  Associations Between Air Pollution Exposure and Empirically Derived Profiles of Cognitive Performance in Older Women.

Authors:  Andrew J Petkus; Diana Younan; Xinhui Wang; Daniel P Beavers; Mark A Espeland; Margaret Gatz; Tara Gruenewald; Joel D Kaufman; Helena C Chui; Joshua Millstein; Stephen R Rapp; JoAnn E Manson; Susan M Resnick; Gregory A Wellenius; Eric A Whitsel; Keith Widaman; Jiu-Chiuan Chen
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

5.  Class-Specific Incidence of All-Cause Dementia and Alzheimer's Disease: A Latent Class Approach.

Authors:  Andrea R Zammit; Charles B Hall; Mindy J Katz; Graciela Muniz-Terrera; Ali Ezzati; David A Bennett; Richard B Lipton
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Clustering of Alzheimer's and Parkinson's disease based on genetic burden of shared molecular mechanisms.

Authors:  Mohammad Asif Emon; Ashley Heinson; Ping Wu; Daniel Domingo-Fernández; Meemansa Sood; Henri Vrooman; Jean-Christophe Corvol; Phil Scordis; Martin Hofmann-Apitius; Holger Fröhlich
Journal:  Sci Rep       Date:  2020-11-05       Impact factor: 4.379

7.  Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease.

Authors:  Jeffrey S Phillips; Fulvio Da Re; David J Irwin; Corey T McMillan; Sanjeev N Vaishnavi; Sharon X Xie; Edward B Lee; Philip A Cook; James C Gee; Leslie M Shaw; John Q Trojanowski; David A Wolk; Murray Grossman
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

8.  Cognitive heterogeneity in probable Alzheimer disease: Clinical and neuropathologic features.

Authors:  Yuqi Qiu; Diane M Jacobs; Karen Messer; David P Salmon; Howard H Feldman
Journal:  Neurology       Date:  2019-07-18       Impact factor: 11.800

9.  Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications.

Authors:  Daniel Ferreira; Chloë Verhagen; Juan Andrés Hernández-Cabrera; Lena Cavallin; Chun-Jie Guo; Urban Ekman; J-Sebastian Muehlboeck; Andrew Simmons; José Barroso; Lars-Olof Wahlund; Eric Westman
Journal:  Sci Rep       Date:  2017-04-18       Impact factor: 4.379

10.  Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling.

Authors:  Lora Minkova; Elisa Scheller; Jessica Peter; Ahmed Abdulkadir; Christoph P Kaller; Raymund A Roos; Alexandra Durr; Blair R Leavitt; Sarah J Tabrizi; Stefan Klöppel
Journal:  Front Hum Neurosci       Date:  2015-11-25       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.